药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Codeine-N-oxide
Lacosamide
Lacosamide may increase the bradycardic activities of Dexverapamil.
Codeine-N-oxide
Poractant alfa
Poractant alfa may increase the bradycardic activities of Dexverapamil.
Codeine-N-oxide
Lanreotide
Lanreotide may increase the bradycardic activities of Dexverapamil.
Codeine-N-oxide
Beractant
Beractant may increase the bradycardic activities of Dexverapamil.
Codeine-N-oxide
Calfactant
Calfactant may increase the bradycardic activities of Dexverapamil.
Codeine-N-oxide
Lucinactant
Lucinactant may increase the bradycardic activities of Dexverapamil.
Codeine-N-oxide
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Dexverapamil.
Codeine-N-oxide
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Dexverapamil.
Codeine-N-oxide
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Dexverapamil.
Codeine-N-oxide
Aripiprazole lauroxil
The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Dexverapamil.
Codeine-N-oxide
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Dexverapamil.
Codeine-N-oxide
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Dexverapamil.
Codeine-N-oxide
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Dexverapamil.
Codeine-N-oxide
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Dexverapamil.
Codeine-N-oxide
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Dexverapamil.
Codeine-N-oxide
Triclabendazole
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Dexverapamil.
Codeine-N-oxide
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Dexverapamil.
Codeine-N-oxide
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Dexverapamil.
Codeine-N-oxide
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Dexverapamil.
Codeine-N-oxide
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Dexverapamil.